A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
by on Thursday, August 30th, 2012 | No Comments
Conditions: Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer
Interventions: Drug: siG12D LODER; Drug: Gemcitabine or FOLFIRINOX
Sponsors: Silenseed Ltd; Silenseed Ltd
Not yet recruiting – verified August 2012
See original here: A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer